American Journal of Analytical Chemistry

Volume 2, Issue 1 (February 2011)

ISSN Print: 2156-8251   ISSN Online: 2156-8278

Google-based Impact Factor: 1.71  Citations  h5-index & Ranking

Identification of Degradant Impurity in Gefitinib by Using Validated RRLC Method

HTML  Download Download as PDF (Size: 1405KB)  PP. 75-83  
DOI: 10.4236/ajac.2011.21008    8,399 Downloads   17,465 Views  Citations

Affiliation(s)

.

ABSTRACT

Degradation pathway for gefitinib is established as per ICH recommendations by validated and stability in-dicating reverse phase liquid chromatographic method. Gefitinib is subjected to stress conditions of acid, base, oxidation, thermal and photolysis. Significant degradation is observed in acid and base stress condi-tions. Two impurities are studied among which one impurity is found prominent degradant. The stress sam-ples are assayed against a qualified reference standard and the mass balance is found close to 99.5%. Effi-cient chromatographic separation is achieved on a Agilent make XDB-C18, 50 × 4.6 mm with 1.8 µm parti-cles stationary phase with simple mobile phase combination delivered in gradient mode and quantification is carried at 250 nm at a flow rate of 0.5 mL?min-1. In the developed RPLC method the resolution between ge-fitinib and the potential impurities is found to be greater than 5.0. Regression analysis shows an r value (cor-relation coefficient) of greater than 0.998 for gefitinib and the two potential impurities. This method is capa-ble to detect the impurities of gefitinib at a level of 0.01% with respect to test concentration of 0.5 mg?mL-1 for a 4-µL injection volume. The developed RRLC method is validated with respect to specificity, linearity & range, accuracy, precision and robustness for impurities determination and assay determination.

Share and Cite:

Venkataramanna, M. , Somaraju, I. and Babu, K. (2011) Identification of Degradant Impurity in Gefitinib by Using Validated RRLC Method. American Journal of Analytical Chemistry, 2, 75-83. doi: 10.4236/ajac.2011.21008.

Cited by

[1] Optimization and validation of stability indicating RP-HPLC method for the quantification of gefitinib in bulk drug and nanoformulations: An application towards …
Arabian Journal of …, 2022
[2] Derivative spectrophotometric methods for determination of gefitinib in bulk and in formulation
Journal of Applied Spectroscopy, 2021
[3] A new stability indicating RP-HPLC method for the estimation of gefitinib tablets using an ion pairing agent
Research Journal of Pharmacy and …, 2021
[4] Method Development and Validation of a New Stability Indicating Reverse Phase Ultra-fast Liquid Chromatographic Method for the Determination of Gefitinib …
Asian Journal of Pharmaceutics (AJP), 2021
[5] Separation, Identification and Quantification of process related Impurities and Stress Degradants of Gefitinib by LC-ESI-Q–TOF/MS
2018
[6] Separation, Identification and Quantification of process related Impurities and Stress Degradants of Gefitinib by LC-ESI-Q TOF/MS
System, 2018
[7] Analytical Methods of Six FDA Approved Molecular Entities Used for the Treatment of Non-Small Cell Lung Cancer: A Concise Review
International journal of Pharmacy, 2018
[8] Separation and Estimation of Intermediates Formed During Synthesis of Gefitinib via 4-Methylthio-Quinazoline Route Using High Performance Liquid Chromatography
Journal of Liquid Chromatography & Related Technologies, 2015
[9] Gefitinib AFM Motiur Rahman*, Hesham M. Korashy?
Profiles of Drug Substances, Excipients and Related Methodology, 2014
[10] An Approach design and characterization of Niosomes for chlorpheniramine maleate
World Journal of Pharmaceutical research, 2014
[11] Gefitinib
Profiles of Drug Substances, Excipients and Related Methodology, 2014
[12] Chapter Five Gefitinib
Profiles of Drug Substances, Excipients and Related Methodology volume 39, 2014
[13] Determination of simvastatin and gefitinib in binary mixture using spectrophotometric, chemometric assisted spectrophotometric and high performance liquid …
2014
[14] DETERMINATION OF SIMVASTATIN AND GEFITINIB IN BINARY MIXTURE USING SPECTROPHOTOMETRIC, CHEMOMETRIC - ASSISTED SPECTROPHOTOMETRIC AND HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC METHODS
World Journal of Pharmaceutical research, 2013
[15] Separation and Estimation of Process-Related Impurities of Gefitinib by Reverse-Phase High-Performance Liquid Chromatography
Journal of chromatographic science, 2013
[16] NEW SPECTROPHOTOMETRIC METHODS FOR THE ESTIMATION OF GEFITINIB IN BULK DRUG AND FORMULATIONS
Int. J. Chem. Res., 2012

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.